Humacyte Inc (HUMA) Event May 13, 2022, 00:00 UTC (52% Neutral) Humacyte, Inc. (HUMA) Reports Net Loss for 2022-03-31 Full text
Register to leave comments News bot Oct. 29, 2025, 8:57 a.m. 🏢 Humacyte Inc (HUMA) - Form 10-Q Quarterly Report Quarterly financial filing submitted to the SEC 📋 Filing Information 📄 Form Type: 10-Q 📅 Filing Date: 2022-05-13 📊 Period of Report: 2022-03-31 ⏰ Accepted: N/A 📊 Key Financial Metrics (Period-over-Period Comparison) Metric Current Period Previous Period Change ($) Change (%) Trend Net Income/Loss $-20.30M $-19.80M $-500.00K -2.53% ↘️ Total Assets $286.53M $264.47M $22.07M +8.34% 📈 Total Liabilities $164.36M $160.58M $3.78M +2.35% ↗️ Stockholders' Equity $-365.52M $-408.40M $42.87M +10.50% 📈 Operating Income/Loss $-19.77M $-21.76M $1.99M +9.16% 📉 R&D Expense $15.14M $16.31M $-1.18M -7.21% 📈 Earningspersharebasic $-3.46 $-0.19 $-3.27 -1721.05% 📉 Earningspersharediluted $-3.46 $-0.19 $-3.27 -1721.05% 📉 📈 Financial Trend Analysis 🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities 📎 View Full 10-Q Filing on SEC.gov Access the complete official filing document
🏢 Humacyte Inc (HUMA) - Form 10-Q Quarterly Report
📋 Filing Information
Key Financial Metrics (Period-over-Period Comparison)
Financial Trend Analysis
🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities
📎 View Full 10-Q Filing on SEC.gov
Access the complete official filing document